NO20055170L - Organiske forbindelser - Google Patents

Organiske forbindelser

Info

Publication number
NO20055170L
NO20055170L NO20055170A NO20055170A NO20055170L NO 20055170 L NO20055170 L NO 20055170L NO 20055170 A NO20055170 A NO 20055170A NO 20055170 A NO20055170 A NO 20055170A NO 20055170 L NO20055170 L NO 20055170L
Authority
NO
Norway
Prior art keywords
organic compounds
ceramide
desoxyascomycin
epichloro
xerosis
Prior art date
Application number
NO20055170A
Other languages
English (en)
Other versions
NO20055170D0 (no
Inventor
Maximillan Grassberger
Stefan Hirsch
Anton Stuetz
Nabila Sekkat
Karl Friedrich Mayer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20055170D0 publication Critical patent/NO20055170D0/no
Publication of NO20055170L publication Critical patent/NO20055170L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Det beskrives synergistiske kombinasjoner av en makrolid T-celle immunomodulator eller - irrmiunosuppressant som 33-epiklor-33-desoksyascomycin og et ceramid som ceramid 3, LPC-9S eller linolensyre. Disse firmer særlig anvendelse ved terapi av dermatologiske eller mukosale sykdorrmier som atpisk eller kontaktdermatitt eller tørr hud, asteatotisk eksem eller xerose.
NO20055170A 2003-04-04 2005-11-03 Organiske forbindelser NO20055170L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0307867.2A GB0307867D0 (en) 2003-04-04 2003-04-04 Pharmaceutical composition
PCT/EP2004/003514 WO2004087202A2 (en) 2003-04-04 2004-04-02 Pharmaceutical composition comprising a macrolide immunomodulator

Publications (2)

Publication Number Publication Date
NO20055170D0 NO20055170D0 (no) 2005-11-03
NO20055170L true NO20055170L (no) 2006-01-04

Family

ID=9956230

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055170A NO20055170L (no) 2003-04-04 2005-11-03 Organiske forbindelser

Country Status (12)

Country Link
US (2) US20070021377A1 (no)
EP (1) EP1638558A2 (no)
JP (1) JP2006522060A (no)
CN (1) CN1764455A (no)
BR (1) BRPI0409169A (no)
CA (1) CA2519958A1 (no)
GB (1) GB0307867D0 (no)
IS (1) IS8103A (no)
MX (1) MXPA05010704A (no)
NO (1) NO20055170L (no)
RS (1) RS20050723A (no)
WO (1) WO2004087202A2 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2885491B1 (fr) * 2005-05-16 2020-03-06 Nutricos Technologies Traitement de la secheresse keratinique par des glycerides
DE102007052380A1 (de) * 2007-10-31 2009-05-07 Bitop Ag Osmolythaltige Zubereitungen zur Anwendung bei trockenen Schleimhäuten
CN120754078A (zh) * 2024-07-30 2025-10-10 中山大学 亚油酸在制备提高革兰氏阳性菌对抗生素敏感性药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9221220D0 (en) * 1992-10-09 1992-11-25 Sandoz Ag Organic componds
FR2710527B1 (fr) * 1993-09-30 1995-12-08 Roussel Uclaf Nouvelles compositions cosmétiques et dermatologiques associant céramides et acide linoléique, leur préparation.
JPH08133979A (ja) * 1994-09-16 1996-05-28 Sando Yakuhin Kk 局所適用薬剤組成物
ATE299017T1 (de) * 1994-10-26 2005-07-15 Novartis Pharma Gmbh Arzneimittel
DE19544507B4 (de) * 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
GB9601120D0 (en) * 1996-01-19 1996-03-20 Sandoz Ltd Organic compounds
DK1064942T3 (da) * 1998-03-26 2004-11-01 Fujisawa Pharmaceutical Co Sustained release-fremstilling af et makrolid
GB0003932D0 (en) * 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions
GB0125443D0 (en) * 2001-10-23 2001-12-12 Novartis Ag Organic Compounds
GB0200429D0 (en) * 2002-01-09 2002-02-27 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
BRPI0409169A (pt) 2006-04-11
CA2519958A1 (en) 2004-10-14
AU2004226822A1 (en) 2004-10-14
CN1764455A (zh) 2006-04-26
NO20055170D0 (no) 2005-11-03
GB0307867D0 (en) 2003-05-14
WO2004087202A2 (en) 2004-10-14
RS20050723A (sr) 2007-11-15
JP2006522060A (ja) 2006-09-28
EP1638558A2 (en) 2006-03-29
WO2004087202A3 (en) 2005-02-03
US20070021377A1 (en) 2007-01-25
US20080132534A1 (en) 2008-06-05
MXPA05010704A (es) 2005-12-12
IS8103A (is) 2005-10-31

Similar Documents

Publication Publication Date Title
NO20081041L (no) PPar aktive forbindelser
NO20055136L (no) Farmasoytisk sammensetning som innbeffatter et immunosuppressivt stoff for bruk ved behandling av hudsykdommer
WO2006099285A3 (en) Percutaneous endoscopic access tools for the spinal epidural space and related methods of treatment
WO2006015263A3 (en) Lonidamine analogs
EP1266959A3 (en) Devices and method for cell harvesting
NO20071549L (no) Nye benzofuserte heteroalrylsulfamidderivater, anvendelige som anti-krampemidler
UY30468A1 (es) Compuestos quimicos.
WO2008003007A3 (en) Compositions and methods for treating parasitic infections
CR11339A (es) Combinaciones que comprenden una cepa fungicida y un compuesto activo
WO2004052177A3 (en) Cell-based therapies for ischemia
AU2011202385A1 (en) Methods, compositions and devices for inducing stasis in cells, tissues, organs, and organisms
DK1761266T3 (da) Forbindelser, formuleringer og fremgangsmåder til at behandle eller forebygge inflammatoriske hudsygdomme
NO20084024L (no) Imidazolbaserte forbindelser, preparater omfattende slike, og anvendelse av slike
BRPI0818366A2 (pt) Composto, pró-droga, medicamento, método inibidor de faah, métodos de profilaxia ou tratamento para ansiedade, ou depressão, ou de alívio da dor, e de profilaxia ou tratamento para dor inflamatória ou dor neuropática, e, uso do composto.
WO2006075330A3 (en) Methods and pharmaceutical compositions useful for treating psoriasis
WO2003075858A3 (en) Bicyclic heterocycles for the treatment of diabetes and other diseases
Maurey Banach spaces with few operators
NO20062709L (no) Stamceller som er egnet for transplantasjon, fremstilling derav og farmasoytiske preperater omfattende nevnte stamceller
CL2004001473A1 (es) Procedimiento para producir neuronas desde celulas mesenquimatosas no diferenciadas y composicion que las contiene.
CY1109666T1 (el) Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας
NO20055474L (no) Mediatorer av revers kolesteroltransport for behandling av hyperkolesterolemi
NO20092134L (no) Kombinasjonsprodukt for bruk i behandling av inflammatoriske lidelser
NO20055170L (no) Organiske forbindelser
ATE411279T1 (de) Arylsulfonamidobenzylverbindungen
TWI372047B (en) Topical pain relief compositions of n,2,3-trimethyl-2-isopropylbutamide and methods for using the same

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application